marijuana stocks news

Form 8-K for 22ND CENTURY GROUP, INC.

29-Dec-2014

Completion of Acquisition or Disposition of Assets, Regulation FD Disclo

Item 2.01 Completion of Acquisition or Disposition of Assets.On December 23, 2014, a wholly-owned subsidiary of 22nd Century Group, Inc. (collectively, the “Company”) purchased intellectual property (both patents and patent applications) from the National Research Council of Canada (“NRC”) relating to the modification of nicotine in the tobacco plant pursuant to the terms of a Purchase Agreement, dated December 22, 2014 (the “Purchase Agreement”), between NRC and the Company’s wholly-owned subsidiary. The Company agreed to pay NRC a total of $1,873,000 (United States Dollars) for the purchase of such intellectual property, of which $873,000 was paid by the Company to NRC at the closing on December 23, 2014, with the remainder of the purchase price being payable by the Company to NRC in three (3) annual installment payments of $333,333.33 on or before December 22, 2015, $333,333.33 on or before December 22, 2016 and $333,333.34 on or before December 22, 2017.

The foregoing description of the Purchase Agreement is not complete and is qualified in its entirety by reference to the exhibit attached to this Current Report on Form 8-K and is incorporated by reference herein.

Item 7.01 Regulation FD.On December 29, 2014, the Company issued a press release announcing the transaction described above and also providing a business update. A copy of the press release is furnished herewith as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01(d) Financial Statements and Exhibits.Exhibit 2.1 Purchase Agreement, dated December 22, 2014, by and between 22nd Century Limited, LLC and the National Research Council of Canada.�

Exhibit 99.1 Press Release dated December 29, 2014.

�Schedules and other similar attachments have been omitted pursuant to Item 601(b)(2) of Regulation S-K. 22nd Century hereby undertakes to furnish supplementally copies of any of the omitted schedules and attachments upon request by the U.S. Securities and Exchange Commission.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

INSYS Therapeutics, Inc. (INSY) Completes Initial Clinical Study of Dronabinol Inhalation

INSYS Therapeutics Completes Initial Clinical Study of Dronabinol Inhalation with Innovative Breath-Actuated…

Curaleaf Holdings, Inc. (CURLF) Completes Acquisition of Tryke Companies

Curaleaf Completes Acquisition of Tryke Companies Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX:…

$VHUB Markets the Limitless Mod

Vapor Hub International Markets the Limitless Mod: Affordable and Revolutionary SIMI VALLEY,…